Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

67.82
-0.4800-0.70%
Volume:293.49K
Turnover:20.13M
Market Cap:13.28B
PE:-19.00
High:69.99
Open:69.26
Low:67.69
Close:68.30
52wk High:93.42
52wk Low:48.78
Shares:195.81M
Float Shares:167.00M
Volume Ratio:0.42
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-5.28
PE(LYR):-17.92

Loading ...

BridgeBio Pharma, Inc. : H.c. Wainwright Raises Target Price to $110 From $100

THOMSON REUTERS
·
May 11

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), BridgeBio Pharma (BBIO) and Globus Medical (GMED)

TIPRANKS
·
May 11

U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla

Reuters
·
May 11

A Look At BridgeBio Pharma (BBIO) Valuation After Strong Long Term Gains And Recent Share Price Weakness

Simply Wall St.
·
May 11

BRIEF-Bridgebio Pharma reports inducement grants under Nasdaq listing rule 5635(C)(4)

Reuters
·
May 09

BridgeBio grants 115,007 restricted stock units to 52 new employees

Reuters
·
May 09

BridgeBio price target raised to $130 from $125 at Evercore ISI

TIPRANKS
·
May 09

BridgeBio price target lowered to $94 from $98 at Morgan Stanley

TIPRANKS
·
May 08

BridgeBio Pharma Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
May 08

BridgeBio Pharma launches at-the-market equity program for up to $500 million

Reuters
·
May 08

RBC Capital Remains a Buy on BridgeBio Pharma (BBIO)

TIPRANKS
·
May 08

BridgeBio price target raised to $114 from $100 at Bernstein

TIPRANKS
·
May 08

BridgeBio files automatic mixed securities shelf

TIPRANKS
·
May 08

BRIEF-BridgeBio Pharma Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing

Reuters
·
May 08

BridgeBio Pharma Inc: Prospectus Supplement Covering Offering of up to $500 Mln of Common Stock

THOMSON REUTERS
·
May 08

Analysts Offer Insights on Healthcare Companies: Vericel (VCEL) and BridgeBio Pharma (BBIO)

TIPRANKS
·
May 08

BridgeBio Pharma posts corporate presentation outlining rare-disease pipeline, commercial strategy

Reuters
·
May 08

BridgeBio Pharma Q1 EPS $(0.84) Misses $(0.67) Estimate, Sales $194.515M Beat $177.937M Estimate

Benzinga Earnings
·
May 08

BRIEF-BridgeBio Pharma Q1 Net Income USD -166.555 Million

Reuters
·
May 08

BridgeBio Pharma Inc - Anvisa Approves Beyonttra (Acoramidis) for Attr-Cm in Brazil on May 4, 2026

THOMSON REUTERS
·
May 08